Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)

Detalles Bibliográficos
Autores principales: Flora, Akshay, Holland, Richard, Smith, Annika, Frew, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255171/
https://www.ncbi.nlm.nih.gov/pubmed/34258349
http://dx.doi.org/10.1016/j.jdcr.2021.05.029
_version_ 1783717856896090112
author Flora, Akshay
Holland, Richard
Smith, Annika
Frew, John W.
author_facet Flora, Akshay
Holland, Richard
Smith, Annika
Frew, John W.
author_sort Flora, Akshay
collection PubMed
description
format Online
Article
Text
id pubmed-8255171
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82551712021-07-12 Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab) Flora, Akshay Holland, Richard Smith, Annika Frew, John W. JAAD Case Rep Case Report Elsevier 2021-06-06 /pmc/articles/PMC8255171/ /pubmed/34258349 http://dx.doi.org/10.1016/j.jdcr.2021.05.029 Text en © 2021 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Flora, Akshay
Holland, Richard
Smith, Annika
Frew, John W.
Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title_full Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title_fullStr Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title_full_unstemmed Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title_short Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)
title_sort rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (sapho) syndrome with il-23p19 antagonist (risankizumab)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255171/
https://www.ncbi.nlm.nih.gov/pubmed/34258349
http://dx.doi.org/10.1016/j.jdcr.2021.05.029
work_keys_str_mv AT floraakshay rapidandsustainedremissionofsynovitisacnepustulosishyperostosisandosteitissaphosyndromewithil23p19antagonistrisankizumab
AT hollandrichard rapidandsustainedremissionofsynovitisacnepustulosishyperostosisandosteitissaphosyndromewithil23p19antagonistrisankizumab
AT smithannika rapidandsustainedremissionofsynovitisacnepustulosishyperostosisandosteitissaphosyndromewithil23p19antagonistrisankizumab
AT frewjohnw rapidandsustainedremissionofsynovitisacnepustulosishyperostosisandosteitissaphosyndromewithil23p19antagonistrisankizumab

Ejemplares similares